Economics at your fingertips  

The Introduction of Cost Sharing for Prescription drugs: Evidence from The Irish Longitudinal Study of Ageing (TILDA)

Gretta Mohan, Anne Nolan and Frank Moriarty
Additional contact information
Gretta Mohan: Economic and Social Research Institute
Anne Nolan: Economic and Social Research Institute
Frank Moriarty: Royal College of Surgeons in Ireland

The Economic and Social Review, 2021, vol. 52, issue 1, 1-40

Abstract: Ageing populations and age-related morbidity present major challenges for advanced economies in managing rapidly increasing pharmaceutical expenditures. However, older people, particularly those with low incomes, may be susceptible to negative effects from cost sharing for medicines. The impact of introducing prescription drug co-payments for older publicly-insured patients (medical cardholders) in Ireland using data from The Irish Longitudinal Study on Ageing is explored. Descriptive evidence revealed that medicines use increased despite the imposition of small co-payments for medical cardholders relative to trends for private patients. However, features of the Irish market must be taken into account in interpreting this counterintuitive result.

Keywords: ageing; prescription medication; Ireland (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations: Track citations by RSS feed

Downloads: (external link) (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this article

More articles in The Economic and Social Review from Economic and Social Studies
Bibliographic data for series maintained by Aedin Doris ().

Page updated 2022-08-31
Handle: RePEc:eso:journl:v:52:y:2021:i:1:p:1-40